Problem-solving articles |
Rubis L.V.
From conventional infections to infections causing public health emergencies
|
6-10 |
Epidemic situation |
Bashketova N.S., Fridman R.К., Kataeva I.S., Shapar A.O., Kostina M.A., Zhuravlev A.S., Lizinfeld I.A., Pshenichnaya N.Yu.
Analysis of the prevalence and structure of asymptomatic SARS-CoV-2 carriage among adolescents and adults in Saint Petersburg during the COVID-19 epidemic rise in January 2022
|
11-17 |
Original investigations |
Zadoroshnyi A.V., Pshenichnaya N.Yu., Akimkin V.G.
Features of the clinical course and the COVID-19 epidemic process in the communities of various planning patterns
|
18-24 |
Zhukova E.V., Nikitina G.Yu., Nozdracheva A.V., Orlova O.A., Gotvyanskaya T.P., Burova A.A., Maziy S.A.
Multidisciplinary approach to assessing the risks of healthcare-associated infections in the context of the COVID-19 pandemic
|
25-34 |
Grishaeva A.A., Ponezheva Zh.B., Chanyshev M.D., Aleshina N.I., Myasnikova M.A., Krasnova S.V.
Macrophage inflammatory proteins as markers of severe COVID-19
|
35-38 |
Belyaeva V.V., Kozyrina N.V., Sokolova E.V., Semikova S.Yu., Galiullin N.I., Bekbolotov A.A., Beshimov A.T., Berdalieva T.Ch., Narkevich A.N., Lebedeva E.P., Suvorova Z.K., Khokhlova O.N., Shegai M.M.
HIV treatment adherence technology: analysis of communications in the specialist-patient system
|
39-45 |
Stepanova E.V., Leonova O.N., Buzunova S.A.
Analysis of the established disability group in HIV-infected patients
|
46-52 |
Volkova S.B., Podymova A.S.
Demographic and clinical characteristics of patients with new-onset HIV/CHC coinfection with the known HCV genotype
|
53-59 |
Omarova Kh.G., Makashova V.V., Ponezheva Zh.B.
The features of the course of HBV infection during antiviral therapy
|
60-63 |
Davidova N.G., Golubkova A.A., Platonova T.A.
Strategic directions for measles infection control in healthcare facilities (according to the analysis of the outbreak in a children hospital)
|
64-69 |
Bykov I.P., Sergeev A.G., Mishchenko V.A., Vyalykh I.V., Toporkova M.G., Vyatkina L.G., Makhorina T.V.
Clinical forms of tick-borne viral encephalitis in persons with co-infection
|
70-75 |
Ayugin N.I., Zarva I.D., Gavrilova T.A., Khakimova M.I., Botvinkin A.D.
Use of GIS technologies to analyze the spread of enteroviral infection in the urban environment
|
76-80 |
Kovalev D.A., Kuznetsova I.V., Zhirov A.M., Serdyuk N.S., Zhilchenko E.B., Ponomarenko D.G., Vodopyanov A.S., Vodopyanov S.O., Kulichenko A.N.
Genetic typing of Brucella melitensis strains on the basis of variability analysis of INDEL loci
|
81-86 |
Matievskaya N.V., Volosach O.S., Kuzmich I.A.
Pseudomonas aeruginosa infection in inpatients of different profiles: clinical and microbiological aspects
|
87-92 |
Заметки из практики |
Karpovich G.S., Kuimova I.V., Serova Yu.S.
СOVID-19 as a probable trigger factor for autoimmune diseases in children
|
93-100 |
Reviews and lectures |
Shchipeleva I.A., Kretenchuk O.F., Korshenko V.A., Markovskaya E.I.
Current status and prospects for specific plague prevention
|
101-109 |
Exchange of experience |
Kryshen K.L., Volok V.P., Shustova E.Yu., Shipunov G.A., Zinchenko A.V., Samsonov M.Yu., Filon O.V., Shipaeva E.V.
Antiviral activity of favipiravir against novel delta and omicron SARS-CoV-2 variants
|
110-114 |
Rakityanskaya I.A., Ryabova T.S., Kalashnikova A.A.
Effect of alloferon on the cytotoxic activity of NK cells in patients with chronic Epstein-Barr virus infection
|
115-120 |